PDS Biotechnology Management
Management criteria checks 3/4
PDS Biotechnology's CEO is Frank Bedu-Addo, appointed in Mar 2019, has a tenure of 4.75 years. total yearly compensation is $2.30M, comprised of 23.5% salary and 76.5% bonuses, including company stock and options. directly owns 2.22% of the company’s shares, worth $3.63M. The average tenure of the management team and the board of directors is 2.9 years and 4.8 years respectively.
Key information
Frank Bedu-Addo
Chief executive officer
US$2.3m
Total compensation
CEO salary percentage | 23.5% |
CEO tenure | 4.8yrs |
CEO ownership | 2.2% |
Management average tenure | 2.9yrs |
Board average tenure | 4.8yrs |
Recent management updates
Recent updates
PDS Biotech jumps 13% as FDA clears further development of lead asset
Oct 03PDS Biotechnology files for $150 mixed shelf offering
Aug 24PDS Biotech spikes as panel backs continuation of cancer trial for lead asset
Aug 04PDS Biotechnology (NASDAQ:PDSB) Is In A Strong Position To Grow Its Business
Jul 08PDS Biotechnology: Speculative Biotech Worth Buying After Latest Data
May 27PDS Biotechnology: Versamune Platform Targeting HPV-Associated Cancers
Feb 22PDS Biotech: Looking Attractive Despite 52-Week High Price
Sep 19PDS Biotech under pressure after pricing equity offering at $8.50
Jun 15PDS Biotech announces preliminary efficacy readout from phase 2 combo trial of PDS0101
Feb 03PDS Biotechnology gives new CFO ~202K stock grant
Jan 06PDS Biotech launches mid-stage PDS0101 combo trial in head & neck cancer
Nov 10CEO Compensation Analysis
Date | Total Comp. | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$51m |
Jun 30 2023 | n/a | n/a | -US$48m |
Mar 31 2023 | n/a | n/a | -US$42m |
Dec 31 2022 | US$2m | US$540k | -US$41m |
Sep 30 2022 | n/a | n/a | -US$28m |
Jun 30 2022 | n/a | n/a | -US$28m |
Mar 31 2022 | n/a | n/a | -US$22m |
Dec 31 2021 | US$7m | US$475k | -US$17m |
Sep 30 2021 | n/a | n/a | -US$15m |
Jun 30 2021 | n/a | n/a | -US$12m |
Mar 31 2021 | n/a | n/a | -US$14m |
Dec 31 2020 | US$815k | US$450k | -US$15m |
Sep 30 2020 | n/a | n/a | -US$15m |
Jun 30 2020 | n/a | n/a | -US$17m |
Mar 31 2020 | n/a | n/a | -US$18m |
Dec 31 2019 | US$3m | US$356k | -US$7m |
Compensation vs Market: Frank's total compensation ($USD2.30M) is above average for companies of similar size in the US market ($USD1.62M).
Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.
CEO
Frank Bedu-Addo (58 yo)
4.8yrs
Tenure
US$2,302,548
Compensation
Dr. Frank K. Bedu-Addo, Ph D., served as Interim Principal Financial Officer for PDS Biotechnology Corporation since September 30, 2021 until October 2021. He serves as Chief Executive Officer of PDS Biote...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.8yrs | US$2.30m | 2.22% $ 3.6m | |
CFO, Principal Financial & Accounting Officer | 2.2yrs | US$504.09k | 0.013% $ 21.4k | |
Chief Medical Officer | 4.8yrs | US$1.01m | 0% $ 0 | |
VP of Research & Development | 2.9yrs | no data | no data | |
Chief Scientific Officer | 4.8yrs | US$1.32m | 0.38% $ 617.8k | |
Head of Investor Relations | no data | no data | no data | |
Senior VP & General Counsel | 1.5yrs | no data | 0% $ 0 | |
Senior Vice President of Business Development | 1.6yrs | no data | no data | |
Controller | no data | no data | no data |
2.9yrs
Average Tenure
59yo
Average Age
Experienced Management: PDSB's management team is considered experienced (2.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.8yrs | US$2.30m | 2.22% $ 3.6m | |
Independent Director | 4.8yrs | US$89.82k | 0.15% $ 242.3k | |
Independent Director | 4.8yrs | US$78.82k | 1.43% $ 2.3m | |
Independent Chairman | 4.7yrs | US$120.32k | 0.21% $ 334.9k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 3.8yrs | US$90.82k | 0.038% $ 61.8k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
4.8yrs
Average Tenure
62yo
Average Age
Experienced Board: PDSB's board of directors are considered experienced (4.8 years average tenure).